Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Cognition Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Cognition Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Cognition Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Cognition Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Cognition Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Cognition Therapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Cognition Therapeutics Raises USD2.4 Million in Venture Financing 10
Cognition Therapeutics Raises USD3 Million in Venture Financing 11
Cognition Therapeutics Raises USD3.5 Million Financing 12
Cognition Therapeutics Raises USD12 Million in Series B Venture Financing 13
Cognition Therapeutics Secures USD15.83 Million in Series B Funding 15
Cognition Therapeutics Raises US$0.14 Million In Venture Financing 16
Cognition Therapeutics Raises US$2 Million In Venture Financing 17
Cognition Therapeutics Inc – Key Competitors 18
Cognition Therapeutics Inc – Key Employees 19
Cognition Therapeutics Inc – Locations And Subsidiaries 20
Head Office 20
Recent Developments 21
Corporate Communications 21
Aug 02, 2017: Cognition Therapeutics Elects Lazard Vice Chairman Stephen Sands to Board of Directors 21
Product News 22
11/08/2017: Cognition Therapeutics CEO Kenneth I. Moch to Present at the Stifel 2017 Healthcare Conference 22
11/04/2017: Cognition Therapeutics’ Alzheimer’s Disease Candidate CT1812 Meets Phase 1b/2a Study Objectives: Well Tolerated with Positive Influence on Biomarkers of Synapse Recovery 23
10/30/2017: Cognition Therapeutics to Present Results of CT1812 Phase 1b/2a Clinical Study as Late Breakers at CTAD Meeting 24
09/07/2017: Cognition Therapeutics CEO Kenneth I. Moch Hosting One-on-Ones at Mizuho Securities CNS Deep Management Day 25
08/23/2017: Function of Cognition Therapeutics’ Neurological Drug Screening Platform Presented at American Chemical Society National Meeting 26
07/31/2017: Cognition Therapeutics CEO Kenneth I. Moch to Present at Canaccord Genuity Annual Growth Conference 27
04/03/2017: Cognition Therapeutics CEO Kenneth I. Moch Presenting at BioCentury Future Leaders Conference 28
03/06/2018: Cognition Therapeutics Co-Founder and CSO Susan Catalano to Present at the Annual ASENT Meeting 29
02/12/2018: Cognition Therapeutics to Participate in Leerink Partners 7th Annual Global Healthcare Conference 30
01/04/2018: Cognition Therapeutics Co-Founder and CSO Susan Catalano to Present at Sachs Neuroscience Innovation Forum 31
Product Approvals 32
Oct 16, 2017: Cognition Therapeutics Receives Fast Track Designation from U.S. FDA for First-in-Class Alzheimer’s Candidate, CT1812 32
Clinical Trials 33
Mar 14, 2018: Cognition Therapeutics Presenting Evidence for Elayta Synaptic Protection in Alzheimer’s Patients at Combined AAT-AD/PD Focus Meeting 33
Jul 19, 2017: Cognition Therapeutics Reports Drug-Drug Interaction Results for CT1812, a Disease-Modifying Alzheimer’s Disease Candidate 34
Appendix 35
Methodology 35
About GlobalData 35
Contact Us 35
Disclaimer 35
Cognition Therapeutics Inc, Pharmaceuticals & Healthcare, Key Facts 2
Cognition Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Cognition Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Cognition Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Cognition Therapeutics Inc, Deals By Therapy Area, 2012 to YTD 2018 9
Cognition Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Cognition Therapeutics Raises USD2.4 Million in Venture Financing 11
Cognition Therapeutics Raises USD3 Million in Venture Financing 12
Cognition Therapeutics Raises USD3.5 Million Financing 13
Cognition Therapeutics Raises USD12 Million in Series B Venture Financing 14
Cognition Therapeutics Secures USD15.83 Million in Series B Funding 16
Cognition Therapeutics Raises US$0.14 Million In Venture Financing 17
Cognition Therapeutics Raises US$2 Million In Venture Financing 18
Cognition Therapeutics Inc, Key Competitors 19
Cognition Therapeutics Inc, Key Employees 20
List of Figures
Cognition Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Cognition Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Cognition Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Cognition Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Cognition Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Cognition Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Cognition Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Cognition Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9